STAAR Surgical Company (STAA)

NASDAQ: STAA · Real-Time Price · USD
26.27
-0.69 (-2.56%)
At close: Oct 24, 2025, 4:00 PM EDT
26.00
-0.27 (-1.03%)
After-hours: Oct 24, 2025, 7:40 PM EDT
-2.56%
Market Cap1.30B
Revenue (ttm)224.45M
Net Income (ttm)-95.27M
Shares Out 49.35M
EPS (ttm)-1.93
PE Ration/a
Forward PE61.09
Dividendn/a
Ex-Dividend Daten/a
Volume869,274
Open26.96
Previous Close26.96
Day's Range25.97 - 27.29
52-Week Range13.50 - 32.00
Beta0.83
AnalystsHold
Price Target22.50 (-14.35%)
Earnings DateNov 6, 2025

About STAA

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) and laser-based procedures, such as LASIK to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors... [Read more]

Sector Healthcare
Founded 1982
Employees 1,157
Stock Exchange NASDAQ
Ticker Symbol STAA
Full Company Profile

Financial Performance

Financial Statements

Analyst Summary

According to 8 analysts, the average rating for STAA stock is "Hold." The 12-month stock price target is $22.5, which is a decrease of -14.35% from the latest price.

Price Target
$22.5
(-14.35% downside)
Analyst Consensus: Hold
Stock Forecasts

News

Yunqi Capital Issues Letter to STAAR Surgical Board Opposing Adjournment of the Special Meeting and Calling for the Company to Move Beyond the Proposed Merger with Alcon

HONG KONG--(BUSINESS WIRE)--Yunqi Capital Limited (together with its affiliates and the funds it advises, “Yunqi Capital”), an investment management firm and 5.1% shareholder of STAAR Surgical Company...

Other symbols: ALC
1 day ago - Business Wire

Broadwood Partners Condemns Decision by STAAR Surgical and Alcon to Delay Final Vote on Proposed Transaction

NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”), which owns 27.5% of the outstanding common stock of STAAR Surgical Company (“STAAR” or the “Company”) (NAS...

Other symbols: ALC
1 day ago - Business Wire

Alcon and STAAR Surgical Announce Adjournment of STAAR Special Meeting of Stockholders

GENEVA & LAKE FOREST, Calif.--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and STAAR Surgical Company (NASDAQ: STAA), the manufact...

Other symbols: ALC
2 days ago - Business Wire

Staar Surgical's top investor calls shareholder meeting to remove directors

Medtech firm Staar Surgical's biggest investor, Broadwood Partners, is planning to call a shareholder meeting to remove several directors, it said on Wednesday, amid tensions over a proposed takeover ...

3 days ago - Reuters

Broadwood Partners Intends to Call Special Meeting to Remove Several STAAR Surgical Directors

NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”), which owns 27.5% of the outstanding common stock of STAAR Surgical Company (“STAAR” or the “Company”) (NAS...

3 days ago - Business Wire

Yunqi Capital Issues Letter to STAAR Surgical's Board Calling for Timely Convening of the Special Meeting to Vote on the Alcon Transaction

HONG KONG--(BUSINESS WIRE)--Yunqi Capital Limited (together with its affiliates and the funds it advises, “Yunqi Capital”), an investment management firm and 5.1% shareholder of STAAR Surgical Company...

Other symbols: ALC
5 days ago - Business Wire

Broadwood Partners Highlights Growing Opposition to STAAR Surgical's Proposed Sale to Alcon

NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”) today commented on the increasing public opposition to the proposed acquisition of STAAR Surgical Company (...

Other symbols: ALC
5 days ago - Business Wire

STAAR Surgical Announces Preliminary Net Sales Results for Third Quarter 2025

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, toda...

5 days ago - Business Wire

Broadwood Partners Issues Letter to STAAR Surgical's Board Urging it to Allow Timely Shareholder Vote on Alcon Sale

NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”) today issued the following letter to the Board of Directors (the “Board”) of STAAR Surgical Company (...

Other symbols: ALC
8 days ago - Business Wire

STAAR Surgical Affirms that No Acquisition Proposals Have Been Received From Any Party Other Than Alcon

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA) (“STAAR”), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correc...

9 days ago - Business Wire

Broadwood Partners: All Three Leading Proxy Advisory Firms Recommend STAAR Surgical Shareholders Vote “AGAINST” Sale to Alcon

NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”) today announced that Institutional Shareholder Services Inc. (“ISS”), a leading independent proxy advisory ...

Other symbols: ALC
10 days ago - Business Wire

Broadwood Partners Comments on STAAR Surgical's Late and Troubling Disclosure in Deeply Flawed Sale Process to Alcon

NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”) today commented on the recent Current Report on Form 8-K filed by STAAR Surgical Company (“STAAR” or the “C...

Other symbols: ALC
11 days ago - Business Wire

Broadwood Partners Issues Letter to STAAR Surgical's Board Questioning Its Diligence in Rush to Reaffirm Support for Alcon Sale

NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”) today issued the following letter to the Board of Directors (the “Board”) of STAAR Surgical Company (...

Other symbols: ALC
15 days ago - Business Wire

STAAR Surgical Board of Directors Reiterates Unanimous Recommendation that STAAR Stockholders Vote “FOR” the Alcon Merger Agreement on WHITE Proxy Card

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA) (“STAAR”), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correc...

Other symbols: ALC
17 days ago - Business Wire

Broadwood Partners: Leading Advisory Firm Glass Lewis Urges STAAR Shareholders to Vote “AGAINST” Sale to Alcon

NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”) today announced that Glass, Lewis & Co., LLC (“Glass Lewis”), a leading independent proxy advisory firm, ha...

Other symbols: ALC
17 days ago - Business Wire

Broadwood Partners Questions Integrity of STAAR Surgical's Last-Minute Forecast Change and Fairness Opinion in Sale to Alcon

NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”) today sent the following letter to the shareholders of STAAR Surgical Company (“STAAR” or the “Company”) (N...

Other symbols: ALC
17 days ago - Business Wire

Defender Capital Opposes STAAR Surgical's Proposed Sale to Alcon

CHARLOTTE, N.C. , Oct. 7, 2025 /PRNewswire/ -- Defender Capital ("Defender" or "we"), a long-term shareholder of STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ: STAA) owning approximately 1...

Other symbols: ALC
18 days ago - PRNewsWire

Yunqi Capital, One of STAAR Surgical Company's Largest Shareholders, Reiterates Its Opposition to the Proposed Merger with Alcon

HONG KONG--(BUSINESS WIRE)--Yunqi Capital Limited (together with its affiliates and the funds it advises, “Yunqi Capital”), an investment management firm and 5.1% shareholder of STAAR Surgical Company...

Other symbols: ALC
19 days ago - Business Wire

Broadwood Partners Issues Letter to STAAR Surgical's Board Questioning Its Judgment in Proposed Sale to Alcon

NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”) today issued the following letter to the Board of Directors (the “Board”) of STAAR Surgical Company (...

Other symbols: ALC
19 days ago - Business Wire

STAAR Surgical: Independent Industry Analysts Recognize Merits of Alcon Merger, the Value It Provides, and the Downside Risks Facing STAAR on Standalone Basis

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, toda...

Other symbols: ALC
19 days ago - Business Wire

STAAR Surgical Addresses Broadwood Partners' Flawed, Misleading, and Misinformed Claims

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, toda...

19 days ago - Business Wire

Johnson Fistel Investigates Fairness of Proposed Sale of STAAR Surgical

SAN DIEGO, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP continues its investigation into whether the board members of STAAR Surgical Company (NASDAQ: STAA) breach...

Other symbols: ALC
22 days ago - GlobeNewsWire

Broadwood Partners Publishes Presentation Detailing Opposition to STAAR Surgical's Sale to Alcon

NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”), holders of approximately 27.5% of the outstanding common stock of STAAR Surgical Company (“STAAR” or...

Other symbols: ALC
22 days ago - Business Wire

BUYOUT INVESTIGATION: Does $28.00 Per Share Buyout Offer Shortchange STAAR Surgical Company (NASDAQ: STAA) Shareholders? Kaskela Law LLC is Investigating the Buyout Offer and Encourages STAA Shareholders to Contact the Firm

PHILADELPHIA , Oct. 1, 2025 /PRNewswire/ -- The law firm of Kaskela Law LLC announces that it is investigating the shareholder buyout offer made to STAAR Surgical Company (NASDAQ: STAA) ("STAAR" or th...

24 days ago - PRNewsWire

Alcon and STAAR Surgical Announce Expiration of Hart-Scott-Rodino Waiting Period for Alcon's Acquisition of STAAR

GENEVA & LAKE FOREST, Calif.--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and STAAR Surgical Company (NASDAQ: STAA) (“STAAR”), th...

Other symbols: ALC
25 days ago - Business Wire